文献
J-GLOBAL ID:201502255347190338
整理番号:15A0633153 プロスタグランジンによる病態制御の最前線【炎症反応におけるプロスタグランジンE2の役割】
- Sugimoto, Y., and S. Narumiya. 2007. Prostaglandin E receptors. J. Biol. Chem. 282: 11613-11617.
- Williams, T. J., and J. Morley. 1973. Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246: 215-217.
- Goulet, J. L., A. J. Pace, M. L. Key, et al. 2004. E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J. Immunol. 173: 1321- 1326.
- Morimoto, K., N. Shirata, Y. Taketomi, et al. 2014. Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. J. Immunol. 192: 1130-1137.
- Dudeck, A., J. Dudeck, J. Scholten, et al. 2011. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34: 973-984.
- Feng, C., E. M. Beller, S. Bagga, et al. 2006. Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. Blood 107: 3243- 3250.
- Brooke, R. C., M. Sidhu, A. Sinha, et al. 2013. Prostaglandin E2 and nitric oxide mediate the acute inflammatory (erythemal) response to topical 5-aminolaevulinic acid photodynamic therapy in human skin. Br. J. Dermatol. 169: 645-652.
- Betz, M., and B. S. Fox, 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146: 108-113.
- Yao, C., D. Sakata, Y. Esaki, et al. 2009. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 15: 633- 640.
- Li, X., F. Murray, N. Koide, et al. 2012. Divergent requirement for G α s and cAMP in the differentiation and inflammatory profile of distinct mouse Th subsets. J. Clin. Invest. 122: 963- 973.
- Yao, C., T. Hirata, K. Soontrapa, et al. 2013. Prostaglandin E2 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase. Nat. Commun. 4: 1685.
前のページに戻る